1. Home
  2. BLZE vs AGMB Comparison

BLZE vs AGMB Comparison

Compare BLZE & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

N/A

Current Price

$6.92

Market Cap

489.2M

Sector

Technology

ML Signal

N/A

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$5.87

Market Cap

576.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLZE
AGMB
Founded
2007
2017
Country
United States
Belgium
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
489.2M
576.2M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
BLZE
AGMB
Price
$6.92
$5.87
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$21.50
★ $37.67
AVG Volume (30 Days)
★ 2.7M
280.7K
Earning Date
11-02-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.56
N/A
EPS
N/A
★ N/A
Revenue
★ $145,835,000.00
N/A
Revenue This Year
$22.07
N/A
Revenue Next Year
$25.20
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.27
N/A
52 Week Low
$3.26
$5.50
52 Week High
$23.99
$17.82

Technical Indicators

Market Signals
Indicator
BLZE
AGMB
Relative Strength Index (RSI) 33.59 25.58
Support Level $6.82 N/A
Resistance Level $9.17 $9.55
Average True Range (ATR) 0.76 0.84
MACD 0.05 -0.03
Stochastic Oscillator 8.02 13.48

Price Performance

Historical Comparison
BLZE
AGMB

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: